Story in numbers: Wasted shots could have vaccinated entire Tripura

In the initial phase, with beneficiaries registering and then not turning up for the vaccine, vials were being discarded to avoid transporting them back to the cold chain

coronavirus, vaccine
Business Standard New Delhi
2 min read Last Updated : Apr 25 2021 | 10:24 PM IST
Up to 6.5 per cent of Covid-19 vaccines was wasted in India until March 17, according to the health ministry data. Over 4.4 million doses — more than the population of Tripura — were wasted until April 11, according to a recent NDTV report based on Right to Information (RTI) queries. By April 11, states and Union Territories had used 100 million doses, the report said, leading to a wastage rate of 4.4 per cent.
 
In the initial phase of the vaccination drive, the news of serious adverse events had worried people. With beneficiaries registering and then not turning up for the vaccine, vials were being discarded to avoid transporting them back to the cold chain, said P J Srinivas, joint secretary (south zone) of the Indian Public Health Association, a public health policy organisation. There were also cases of inexperienced vaccinators drawing more than required from vials, leading to wastage, he added.
 
As of March 17, the government data showed, Telangana reported the highest vaccine wastage rate (17.6 per cent), followed by Andhra Pradesh (11.6 per cent), and Uttar Pradesh (9.4 per cent). A month later, the NDTV report said Tamil Nadu reported the highest wastage (12 per cent), followed by Haryana (9.7 per cent), Punjab (8.1 per cent), Manipur (7.8 per cent), and Telangana (7.6 per cent).
 
States and UTs that reported "zero wastage" were Kerala, West Bengal, Himachal Pradesh, Mizoram, Goa, Daman and Diu, Andaman and Nicobar Islands and Lakshadweep, according to the NDTV report. However, the government's vaccine operational guidelines have factored in an allowable wastage of 10 per cent.
 
Wastage will be a criterion when the Centre starts allocating vaccines as per its new, liberalised Covid-19 immunisation strategy starting May 1.

Source: IndiaSpend, NDTV, RTI reply


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineCoronavirus TestsTripuraHealth crisisVaccination

Next Story